Literature DB >> 9766782

Olanzapine use in women with antipsychotic-induced hyperprolactinemia.

C M Canuso, M Hanau, K K Jhamb, A I Green.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766782     DOI: 10.1176/ajp.155.10.1458

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

1.  Olanzapine-induced galactorrhea.

Authors:  Rasmus W Licht; Torben Arngrim; Hilmar Cristensen
Journal:  Psychopharmacology (Berl)       Date:  2002-06       Impact factor: 4.530

2.  Breast enlargement associated with low dose olanzapine.

Authors:  Ashish Aggarwal; Ashish Khandelwal; Manish Jain; R C Jiloha
Journal:  Indian J Pharmacol       Date:  2011-02       Impact factor: 1.200

3.  Pharmacological causes of hyperprolactinemia.

Authors:  Daria La Torre; Alberto Falorni
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

4.  Management of antipsychotic-induced hyperprolactinemia.

Authors:  Ashley Tewksbury; Amy Olander
Journal:  Ment Health Clin       Date:  2016-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.